Literature DB >> 16461997

Eosinophilic gastroenteritis and citrus-induced urticaria.

Arvind Kumar1, Suzanne S Teuber, Stanley Naguwa, Thomas Prindiville, M Eric Gershwin.   

Abstract

The immunological basis of eosinophilic gastroenteritis (EGE) is an interesting contrast between the enigma of urticaria and the increasing usage of molecular technology in clinical allergy. Little is known about the natural history of EGE. It has been known to spontaneously remit, but the typical course, especially in adults, is one of chronic and intermittent disease. Given the often chronic nature of this disease, it is important to use relatively benign treatments initially and limit the use of systemic corticosteroids. Also, given the fact that eosinophilic infiltration of the gastrointestinal tract may also be a manifestation of other potentially dangerous disease processes, such as malignancy or hypereosinophilic syndrome, which may be initially diagnosed as EGE, routine surveillance of the cardiopulmonary and gastrointestinal systems is important. We present a patient who demonstrates the variability of presentation and treatment response in this multifaceted disease. The fact that he has apparently entered remission also makes his an uncommon presentation of EGE.

Entities:  

Mesh:

Year:  2006        PMID: 16461997     DOI: 10.1385/CRIAI:30:1:061

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  75 in total

Review 1.  Eosinophilic gastroenteritis.

Authors:  K J Kelly
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000       Impact factor: 2.839

2.  Barium studies in diffuse eosinophilic gastroenteritis.

Authors:  R L MacCarty; N J Talley
Journal:  Gastrointest Radiol       Date:  1990

3.  GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts.

Authors:  H Kulessa; J Frampton; T Graf
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

4.  Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis.

Authors:  D A Schwartz; D S Pardi; J A Murray
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

5.  Oral administration of cromolyn in a patient with protein-losing enteropathy, food allergy, and eosinophilic gastroenteritis.

Authors:  R G Van Dellen; J C Lewis
Journal:  Mayo Clin Proc       Date:  1994-05       Impact factor: 7.616

6.  IgE antibodies against bovine serum albumin in a case of eosinophilic gastroenteritis.

Authors:  J Verdaguer; M Corominas; J Bas; A Valls; M Mestre; A Romeu; L Gonzalez; E Massip; E Buendia
Journal:  Allergy       Date:  1993-10       Impact factor: 13.146

7.  Mucosal eosinophilic gastroenteritis with systemic involvement.

Authors:  F Robert; E Omura; J R Durant
Journal:  Am J Med       Date:  1977-01       Impact factor: 4.965

8.  Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein.

Authors:  G Torpier; J F Colombel; C Mathieu-Chandelier; M Capron; J P Dessaint; A Cortot; J C Paris; A Capron
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

9.  Eosinophilic gastroenteritis presenting as obstructive jaundice.

Authors:  I S Whitaker; A Gulati; J O McDaid; U Bugajska-Carr; M J Arends
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-04       Impact factor: 2.566

10.  Essential and instructive roles of GATA factors in eosinophil development.

Authors:  Ryutaro Hirasawa; Ritsuko Shimizu; Satoru Takahashi; Mitsujiro Osawa; Shu Takayanagi; Yuko Kato; Masafumi Onodera; Naoko Minegishi; Masayuki Yamamoto; Katashi Fukao; Hideki Taniguchi; Hiromitsu Nakauchi; Atsushi Iwama
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

View more
  4 in total

1.  Dermal immunopathology: from genetics to effector mechanisms.

Authors:  Akira Takashima; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

2.  Vasculitis: current status and future directions.

Authors:  Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

3.  Cutting edge issues in autoimmunity.

Authors:  Yaniv Sherer; Torsten Matthias; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

4.  Whither autoimmunity: the lessons of anti-CCP and B cell depletion.

Authors:  Yehuda Shoenfeld; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.